Northwestern Medicine studies nanoparticle injection for SCI — 5 takeaways Featured

Written by  Megan Wood | Monday, 11 September 2017 18:52
Social sharing

Chicago-based Northwestern Medicine researchers studied the impact of a nanoparticle injection following spinal cord injury, according to Northwestern Now.

Researchers injected mice with SCIs with a nanoparticle injection, composed of poly acid. The FDA has approved the biocompatible substance for re-absorbable sutures.


Here are five takeaways:


1. The mice injected with the nanoparticle could walk better compared to those who didn't receive the injection.


2. The injection works to prevent secondary nerve damage caused by inflammation and internal scarring. The injection does not cure the initial injury.


3. The nanoparticle injection binds the inflammation-causing cells and pushes them toward the spleen.


4. Researchers note the need for further studies to test the the nanoparticle's safety for humans.


5. Stephen Miller, PhD, the Judy Gugenheim Research Professor of Microbiology-Immunology at Chicago-based Feinberg School of Medicine, co-founded Cour Pharmaceuticals Development Co., which is developing the nanoparticle technology.

More articles on spine:
Drs. Jordan Glaser, Jonathan Workman & more: 5 spine, neurosurgeons making headlines
Drug treatment aims to enhance bladder compliance after SCI: 4 takeaways
Study: How do undiagnosed vertebral fractures impact older men?


© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months